Abstract B85: Pathologic complete response following systemic chemotherapy with or without chemoradiotherapy for borderline resectable/unresectable pancreatic adenocarcinoma: Indiana University experience

Conclusion: This case series demonstrates complete pathologic remission in patients receiving neoadjuvant treatment for advanced pancreatic cancer. When compared to OS of patients with metastatic or locally advanced disease who do not achieve pCR or undergo resection, pCR seems to be associated with improved OS. The ideal treatment regimen and duration of treatment in order to achieve higher rates of pCR is yet to be investigated.Citation Format: Neda Hashemi-Sadraei, Hai Nguyen, Bert O’Neil, Michael G. House, Safi Shahda.{Authors}. Pathologic complete response following systemic chemotherapy with or without chemoradiotherapy for borderline resectable/unresectable pancreatic adenocarcinoma: Indiana University experience. [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care; 2016 May 12-15; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2016;76(24 Suppl):Abstract nr B85.
Source: Cancer Research - Category: Cancer & Oncology Authors: Tags: Clinical Investigation Source Type: research